Persistent cystic fibrosis isolate Pseudomonas aeruginosa strain RP73 exhibits an under-acylated LPS structure responsible of its low inflammatory activity

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 166-175

  Di Lorenzo, Flaviana ^a   Silipo, Alba ^a   Bianconi, Irene ^b   Lore', Nicola Ivan ^b   Scamporrino, Andrea ^c   Sturiale, Luisa ^c   Garozzo, Domenico ^c   Lanzetta, Rosa ^a   Parrilli, Michelangelo ^a   Bragonzi, Alessandra ^b   Molinaro, Antonio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Istituto di Chimica e Tecnologia dei Polimeri   (Italy)

Author keywords

Chronic infections in cystic fibrosis; Cystic fibrosis; Lipid A; Lipopolysaccharide; Pseudomonas aeruginosa; Structural analysis

Indexed keywords

DEOXYRIBONUCLEASE; LIPID A; LIPOOLIGOSACCHARIDE; LIPOPOLYSACCHARIDE; PROTEINASE; RIBONUCLEASE; LIPID-LINKED OLIGOSACCHARIDES; PEROXIDASE;

ARTICLE; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG STRUCTURE; ENTAMOEBA COLI; FREEZE DRYING; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; HYDROLYSIS; IMMUNE RESPONSE; INFLAMMATORY ACTIVITY; INNATE IMMUNITY; LUNG LAVAGE; MASS FRAGMENTOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; SILVER STAINING; ACYLATION; ANIMAL; C57BL MOUSE; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MICROBIOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

PSEUDOMONAS AERUGINOSA;

ACYLATION; ANIMALS; CARBON-13 MAGNETIC RESONANCE SPECTROSCOPY; CYSTIC FIBROSIS; INFLAMMATION; LIPID A; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PEROXIDASE; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PSEUDOMONAS AERUGINOSA; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84912010967     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.04.004     Document Type: Article

References (49)

1. Alexander C., Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J. Endotoxin Res. 2001, 7:167-202.
2. 1H NMR analyses. J. Carbohydr. Chem. 1987, 6:17-39.
3. Bock K., et al. Isolation and structural analysis of oligosaccharide phosphates containing the complete carbohydrate chain of the lipopolysaccharide from Vibrio cholerae strain H11 (non-O1). Eur. J. Biochem. 1994, 225:1029-1039.
4. Bragonzi A., et al. Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Microbiology 2006, 152:3261-3269.
5. Bragonzi A., et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. AJRCCM 2009, 180:138-145.
6. Bystrova O.V., et al. Structural studies on the core and the O-polysaccharide repeating unit of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide. Eur. J. Biochem. 2002, 269:2194-2203.
7. Bystrova O.V., et al. Structure of the lipopolysaccharide of Pseudomonas aeruginosa O-12 with a randomly O-acetylated core region. Carbohydr. Res. 2003, 338(18):1895-1905.
8. Bystrova O.V., et al. Full structure of the lipopolysaccharide of Pseudomonas aeruginosa immunotype 5. Biochemistry (Mosc.) 2004, 69(2):170-175.
9. Caroff M., et al. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the isolated lipid A fragment of the Bordetella pertussis endotoxin. Carbohydr. Res. 1988, 175:273-282.
10. Cigana C., et al. Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS ONE 2009, 4(12):e8439.
11. Ciucanu I., Kerek F. A simple and rapid method for the permethylation of carbohydrates. Carbohydr. Res. 1984, 131:209-217.
12. Dean C.R., et al. WbjA adds glucose to complete the O-antigen trisaccharide repeating unit of the lipopolysaccharide of Pseudomonas aeruginosa serogroup O11. J. Bacteriol. 2002, 184(1):323-326.
13. De Castro C., et al. Microbe-associated molecular patterns in innate immunity: extraction and chemical analysis of Gram-negative bacterial lipopolysaccharides. Methods Enzymol. 2010, 480:89-115.
14. De Soyza A., et al. Lipopolysaccharide structure and biological activity from the cystic fibrosis pathogens Burkholderia cepacia complex. Carbohydr. Chem. 2012, 38:13-39.
15. Döring G., et al. Immunologic aspects of cystic fibrosis. Chest 1988, 94:109S-115S.
16. Ernst R.K., et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999, 286:1561.
17. Ernst R.K., et al. Pseudomonas aeruginosa lipid A diversity and its recognition by Toll-like receptor 4. J. Endotoxin Res. 2003, 9:395-400.
18. Galanos C., et al. A new method for the extraction of R lipopolysaccharides. Eur. J. Biochem. 1969, 9:245-249.
19. Gibson R.L., et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2003, 168:918-951.
20. Hajjar A.M., et al. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 2002, 3:354-359.
21. Holst O., et al. Preparation and structural analysis of oligosaccharide monophosphates obtained from the lipopolysaccharide of recombinant strains of Salmonella minnesota and Escherichia coli expressing the genus-specific epitope of Chlamydia lipopolysaccharide. Eur. J. Biochem. 1994, 222:183-194.
22. Holst O., et al. The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-d-manno-octulopyranosonic acid (Kdo) transferase of Chlamydia psittaci 6BC. Eur. J. Biochem. 1995, 229:194-200.
23. Holst O. Endotoxin in Health and Disease 1999, 115-154. Marcel Dekker, New York. H. Brade, D.C. Morrsion, S. Opal, S. Vogel (Eds.).
24. Holst O. Deacylation of lipopolysaccharides and isolation of oligosaccharide phosphates. Methods Mol. Biol. 2000, 145:345-353.
25. Holst O. Chemical structure of the core region of lipopolysaccharides. An update. Trends Glycosci. Glycotechnol. 2002, 14:87-103.
26. Jeukens J., et al. Complete genome sequence of persistent Cystic Fibrosis isolate Pseudomonas aeruginosa strain RP73. Genome Announc. 2013, 1(4). e00568-13.
27. Kittelberger R., Hilbink F.J. Sensitive silver-staining detection of bacterial lipopolysaccharides in polyacrylamide gels. Biochem. Biophys. Methods 1993, 26:81-86.
28. Knirel Y.A., et al. Structural analysis of the lipopolysaccharide core of a rough, cystic fibrosis isolate of Pseudomonas aeruginosa. Eur. J. Biochem. 2001, 268(17):4708-4719.
29. Kocíncová D., Lam J.S. Structural diversity of the core oligosaccharide domain of Pseudomonas aeruginosa lipopolysaccharide. Biochemistry (Mosc.) 2011, 76(7):755-760.
30. Kooistra O., et al. Structure of a highly phosphorylated lipopolysaccharide core in the Delta algC mutants derived from Pseudomonas aeruginosa wild-type strains PAO1 (serogroup O5) and PAC1R (serogroup O3). Carbohydr. Res. 2003, 338(23):2667-2677.
31. Kresse A.U., et al. Impact of large chromosomal inversions on the adaptation and evolution of Pseudomonas aeruginosa chronically colonizing cystic fibrosis lungs. Mol. Microbiol. 2003, 47:145-158.
32. Leontein K., Lönngren J. Determination of the absolute configuration of sugars by gas-liquid chromatography of their acetylated 2-octyl glycosides. Methods Carbohydr. Chem. 1978, 62:359-362.
33. Masoud H., et al. Structural elucidation of the lipopolysaccharide core region of the O-chain-deficient mutant strain A28 from Pseudomonas aeruginosa serotype 06 (International Antigenic Typing Scheme). J. Bacteriol. 1995, 177(23):6718-6726.
34. Moalli F., et al. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J. Immunol. 2011, 186:5425-5434.
35. Paroni M., et al. Response of CFTR-deficient mice to long-term Pseudomonas aeruginosa chronic infection and PTX3 therapy. J. Infect. Dis. 2013, 208:130-138.
36. Piantini U., et al. Multiple quantum filters for elucidating NMR coupling networks. J. Am. Chem. Soc. 1982, 104:6800-6801.
37. Pier G.B. Promises and pitfalls of Pseudomonas aeruginosa lipopolysaccharide as a vaccine antigen. Carbohydr. Res. 2003, 338:2549-2556.
38. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983, 117:479-485.
39. Rowe P.S., Meadow P.M. Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. Eur. J. Biochem. 1983, 132(2):329-337.
40. Sadovskaya I., et al. Structural elucidation of the lipopolysaccharide core regions of the wild-type strain PAO1 and O-chain-deficient mutant strains AK1401 and AK1012 from Pseudomonas aeruginosa serotype O5. Eur. J. Biochem. 1998, 255(3):673-684.
41. Sánchez Carballo P.M., et al. Elucidation of the structure of an alanine-lacking core tetrasaccharide trisphosphate from the lipopolysaccharide of Pseudomonas aeruginosa mutant H4. Eur. J. Biochem. 1999, 261(2):500-508.
42. Silipo A., et al. Ammonium hydroxide hydrolysis: a valuable support in the MALDI-TOF mass spectrometry analysis of Lipid A fatty acid distribution. J. Lipid Res. 2002, 43:2188-2195.
43. Silipo A., et al. The structure of the phosphorylated carbohydrate backbone of the lipopolysaccharide of the phytopathogen bacterium Pseudomonas tolaasii. Carbohydr. Res. 2004, 339:2241-2248.
44. Silipo A., et al. Structure elucidation of the highly heterogeneous lipid A from the lipopolysaccharide of the Gram-negative extremophile bacterium Halomonas magadiensis strain 21 M1. Eur. J. Org. Chem. 2004, 10:2263-2271.
45. Silipo A., et al. Full structural characterisation of the lipooligosaccharide of a Burkholderia pyrrocinia clinical isolate. Eur. J. Org. Chem. 2006, 21:4874-4883.
46. Smith E.E., et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:8487-8492.
47. States D.J., et al. A two-dimensional nuclear Overhauser experiment with pure absorption phase in four quadrants. J. Magn. Reson. 1982, 48:286-292.
48. Stover C.K., et al. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 2000, 406:959-964.
49. Sturiale L., et al. Reflectron MALDI TOF and MALDI TOF/TOF mass spectrometry reveal novel structural details of native lipooligosaccharides. J. Mass Spectrom. 2011, 46:1135-1142.